Mar 28, 2019
Position and Policy Regarding Reduction of the Investment Unit
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Tatsuro Kosaka |
| Inquiries to: | Masahiko Uchida, |
| General Manager, Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
1. Position Regarding Reduction of Investment Unit
Chugai Pharmaceutical Co., Ltd. (the Company) recognizes that a reduction of investment units is one the effective ways to promote liquidity in the equity market as well as to expand the investor base.
2. Policy Regarding Reduction of Investment Unit
The Company will comprehensively examine a number of factors including the trends of the stock market and the Company’s stock price level in order to carefully consider the appropriate decision and timing regarding the reduction of investment unit.
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Tomoko Shimizu
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
